2026 Governance Prescription Drug Pricing 
Hall Render
MAY 10, 2024
Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’
Kaiser Health News
AUGUST 12, 2022
First, it would give the federal government the ability to negotiate prices of some drugs purchased by Medicare beneficiaries, a tool that has long been opposed by the drug industry. Never before have we been able to negotiate prescription drug prices. Those prices would take effect in 2026.
Bill of Health
DECEMBER 3, 2024
According to a House Committee on Oversight and Accountability report , PBMs encourage patients toward higher-cost drugs with greater rebates by placing the products on more favorable tiers. PBMs also can overcharge employers and government programs for prescription drugs due to the opacity of drug pricing.
Expert insights. Personalized for you.
40 
Let's personalize your content